In this issue:
Lymphocyte infiltration: a key prognostic factor?
Exemestane for breast cancer prevention
Duration of chemotherapy for metastatic breast cancer
Outcomes from mastectomy, RT and delayed reconstruction
LHRHa therapy: no protection for ovarian function
Breast density predicts tamoxifen response
Screening mammograms in breast cancer survivors
Management of long-term Hodgkin’s Lymphoma survivors
Patent blue dye and sentinel node biopsy
Please login below to download this issue (PDF)